Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Elan acquires Sano in a $375mm all-stock transaction
13 Jul 1999
Drug delivery biopharmaceutical Elan will acquire Sano, a transdermal delivery company, in a tax-free, all-stock transaction for about $375mm, or $35.50 per share (a (pr)35% premium to the $23 share price the day before the announcement).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?